Rich Murray Founder of Dualitas Therapeutics Backed byAlexandria Venture InvestmentsSV Health InvestorsHouman AshrafianJoel MarcusPaul LaViolette LinkedIn SourcesDualitas Launches With $65 Million Series A to Advance Novel Bispecific Antibody Pipeline in Immune and Inflammatory Disease — 2025-09 Browse all founders · Browse investors
